1448617

Moxifloxacin Related Compound A

United States Pharmacopeia (USP) Reference Standard

• 同義詞: 1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
• 經驗公式（希爾表示法）: C₂₀H₂₁F₂N₃O₃
• CAS號碼: 151213-15-9
• 分子量：: 389.40
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• API 家族: moxifloxacin
• 製造商／商標名: USP
• 應用: pharmaceutical (small molecule)
• 格式: neat
• InChI: 1S/C20H21F2N3O3/c21-14-6-12-17(25(11-3-4-11)8-13(19(12)26)20(27)28)16(22)18(14)24-7-10-2-1-5-23-15(10)9-24/h6,8,10-11,15,23H,1-5,7,9H2,(H,27,28)/t10-,15+/m0/s1
• InChI 密鑰: WEXQOLCYKFJAJZ-ZUZCIYMTSA-N

描述

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

應用

• Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC: Demonstrating the analytical prowess of RP-HPLC, this research utilizes Moxifloxacin Related Compound A to refine and validate methods for the precise quantification and quality control of fluoroquinolone pharmaceuticals, ensuring high standards in drug manufacturing and compliance (Djurdjevic et al., 2009).

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H315,H319,H335
• 防範說明: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• 危險分類: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• 標靶器官: Respiratory system
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable